Hyperaldosteronism: Clinical Trials

5 trials for Hyperaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Hyperaldosteronism: new trials by email Literature Review of Hyperaldosteronism trials Research Report on Hyperaldosteronism

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Finerenone, Spironolactone - Primary Aldosteronism
Phase 4UnknownShanghai Jiao Tong University School of Medicine1502023-12-162023-12-11
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Finerenone, Spironolactone - Primary Aldosteronism, Hypertension
Phase 4UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School962023-05-012023-04-18
Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
Synacthen infusion during adrenal venous sampling - Primary Aldosteronism
Phase 4UnknownCharles University, Czech Republic402011-03-012014-05-01
Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
Eplerenone, Placebo - Hypertension, Dialysis
Phase 4UnknownShaare Zedek Medical Center272007-11-012007-11-06
The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
bromocriptine - Hyperaldosteronism, Hypertension
Phase 4UnknownNational Taiwan University Hospital252007-01-012007-03-23

Narrower conditions

Hypertension (4)  ·  ACTH Syndrome, Ectopic (1)

Broader conditions

Adrenal Gland Diseases (5)  ·  Adrenocortical Hyperfunction (5)  ·  Endocrine System Diseases (5)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Neoplasms (1)  ·  Paraneoplastic Endocrine Syndromes (1)  ·  Paraneoplastic Syndromes (1)

Interventions

Spironolactone (2)  ·  finerenone (2)  ·  Bromocriptine (1)  ·  Eplerenone (1)

Sponsors

Charles University, Czech Republic (1)  ·  National Taiwan University Hospital (1)  ·  Shaare Zedek Medical Center (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

China (1)  ·  Czechia (1)  ·  Israel (1)  ·  Taiwan (1)

Top investigators

Jiguang Wang, MD. PhD (1)  ·  Jiri Ceral, MD (1)  ·  Kwan-Dun Wu, MD, PhD (1)  ·  Linda Shavit, MD (1)  ·  Ping Li (1)  ·  Vin-Cent Wu, MD (1)